Who We Are
NovusThera Inc. is a Canadian privately held pharmaceutical company dedicated to the development, licensing, and marketing of quality sterile injectables and value-added pharmaceutical specialty generics. Our products cater to diverse therapeutic areas, including central nervous system (CNS), hematology, cardiovascular system, neuromuscular disorders, and dermatology.
Focus Products
NovusThera focuses on a diverse range of quality sterile injectables and value-added specialty generics in multiple pharmaceutical forms, including prefilled syringes (PFS), vials, ampoules, and auto-injectors. Our portfolio comprises a unique selection of injectable archetypes, including biologics, long-acting injectables (LAI), complex injectables, and normal injectables.
Partnerships are Paramount
At NovusThera, collaboration and partnerships are paramount, particularly with like-minded and innovative players in the specialty pharmaceutical product sector.
We believe that by collaborating and partnering, we can complement each other’s offerings and leverage our collective expertise to develop innovative solutions that meet the evolving needs of the healthcare industry. Our focus on collaboration enables us to create more comprehensive and effective treatment options, helping us to provide the best possible value to our customers and end-users.
